We are live on ! Find out more
OGEN icon

Oragenics
OGEN

13 hedge funds and large institutions have $10.5M invested in Oragenics in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 13 → 13 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.14% less ownership

Funds ownership: 39.82% → 39.68% (-0.14%)

32% less capital inflows, than outflows

Capital inflows: $55.7K | Capital outflows: $82.1K

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$18.6K
2
Virtu KCG Holdings
Virtu KCG Holdings
New York
+$18.6K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$9.28K
4
UBS Group
UBS Group
Switzerland
+$9.28K

Top Sellers

Rank Fund Capital Flow
1
Bridgeway Capital Management
Bridgeway Capital Management
Texas
-$27.8K
2
Brown Advisory
Brown Advisory
Maryland
-$23K
3
MLM
Mount Lucas Management
Pennsylvania
-$16K
4
Goldman Sachs
Goldman Sachs
New York
-$9.28K
5
Squarepoint
Squarepoint
New York
-$6K

OGEN Hedge Fund Activity: Q4 2016 in Review

13 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2016, worth a combined $10.5M — up 17% from $9M a quarter earlier.

Fund positioning in OGEN was balanced in Q4 2016: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $18.6K. The largest seller was Bridgeway Capital Management, cutting an estimated $27.8K.

  • 13 institutional investors held Oragenics (OGEN) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $10.5M of Oragenics stock for Q4 2016, up 17% quarter-over-quarter.
  • 3 funds opened new Oragenics positions in Q4 2016 and 3 closed out, a net change of 0 holders.
  • The largest Oragenics buyer in Q4 2016 was Vanguard Group, an estimated $18.6K added.
  • The largest Oragenics seller in Q4 2016 was Bridgeway Capital Management, an estimated $27.8K sold.

Based on aggregated 13F filings for Q4 2016.